Skip to content
Menu

Rapid Micro Biosystems, Inc. RPID

Full chart Compare
Set alert

Price alert · RPID

All alert types
0.74 USD 0.00 (-0.31%)

Regular-session close

0.74 0.00 +0.48%

After hours · Nov 19, 4:24 PM ET

0.7353 Day range 0.7366
0.62 52-week range 4.68
YTD
-74.64%
1 year
-83.14%

5D -0.0051 (-0.69%)

0.65000.70000.75000.8000TueWedThuFriMon0.7349
Market cap
37.38M
Revenue (ttm)
26.17M
Profit margin
-184.93%
EPS (ttm)
-1.06
Shares out
37.72M
Forward P/E
-1.02
YTD return
-74.64%
1-year return
-83.14%
Volume
690.48K
Avg volume
550.63K
Open
0.736
Previous close
0.7376
Day's range
0.7353 – 0.7366
52-week range
0.62 – 4.68
Beta
1.08
Price target
8.00 (+988.0%)

Key statistics

50-day average
1.04
200-day average
0.88566
Enterprise value
-15.08M
Price / sales
1.50
Price / book
0.47
Revenue growth
23.70%
Total cash
60.83M
Total debt
6.45M
Return on equity
-45.62%
Short % of float
0.15%

Fundamental scorecard

7 of 25 checks passed on RPID’s reported financials

ValueGrowthProfitabilityHealthDividend

7of 25 checks passed

  • Value 1 of 5
  • Growth 2 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Financials — quick view

All financials
RPID Revenue — quarterly 8.05M
RPID Net income — quarterly -12.92M
RPID EPS — quarterly -0.27

Earnings

RPID recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 1, 2024Sep 1, 2024-0.26-0.260.000.00%
Aug 2, 2024Jun 1, 2024-0.28-0.29-0.01-3.57%
Aug 2, 2024Jun 1, 2024-0.28———
May 3, 2024Mar 1, 2024-0.29-0.31-0.02-6.90%
May 3, 2024Mar 1, 2024-0.29———
Mar 1, 2024Dec 1, 2023-0.31-0.26+0.05+16.13%

Upgrades / downgrades

RPID analyst upgrades and downgrades
DateFirmActionFromTo
Mar 7, 2023Morgan Stanleyreit—Equal-Weight
Aug 16, 2022JP MorgandownOverweightNeutral
May 11, 2022Morgan Stanleymain—Equal-Weight
Mar 7, 2022Morgan Stanleymain—Equal-Weight
Feb 15, 2022Morgan Stanleymain—Equal-Weight
Nov 15, 2021Morgan Stanleymain—Equal-Weight

About Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on RPID — it syncs with the Stock Master app.

Insider holders

RPID insider holders
InsiderRelationLatest transactionDateShares held
HIRSCH DAVIDDirectorStock Award(Grant)May 22, 202414,300
KOLLENDER RICHARD SDirectorPurchaseAug 5, 202496,718
LOWENSTEIN INESEDirectorStock Award(Grant)May 22, 202424,300
MALLOY KIRKDirectorPurchaseAug 7, 202464,300
PEI MELINDA LITHERLANDDirectorPurchaseDec 4, 202454,300
RICCIARDI NATALE SDirectorStock Award(Grant)May 22, 202414,300

Institution ownership

RPID institution ownership
Holder% heldSharesValueReported
Bain Capital Life Sciences Investors, LLC22.36%8,434,5607.69MSep 29, 2024
Kennedy Lewis Management LP13.09%4,939,9314.50MSep 29, 2024
ABG-WTT Global Life Science Capital Partners GP Ltd2.75%1,038,296946.82KSep 29, 2024
Vanguard Group Inc1.93%726,560662.55KSep 29, 2024
Advent International LP1.53%577,777526.87KSep 29, 2024
Blackrock Inc.1.52%572,879522.41KSep 29, 2024

Fund ownership

RPID fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.58%594,568542.19KSep 29, 2024
BlackRock Health Sciences Term Trust1.51%571,184520.86KSep 29, 2024
Vanguard Extended Market Index Fund0.31%116,325106.08KSep 29, 2024
Fidelity Extended Market Index Fund0.23%85,82878.27KOct 30, 2024
Fidelity Series Total Market Index Fund0.06%21,25819.39KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.06%21,52219.63KOct 30, 2024